According to the CF registry report half of pwCF born today are predicted to live to at least 53.3 years,1 as a result of improvements in diagnostic and therapeutic options, and is likely to rise further with recent availability of treatments targeting CFTR mutations. Here, CFTR is linked to cystic fibrosis.